Healthcare & Life Sciences
Versanis Bio
United Statesversanisbio.com
Versanis Bio is a Healthcare & Life Sciences startup based in the United States, since acquired, 1 tracked investor.
Acquiredacquired
acquired
Stage
2017
Founded
1
Investors
About Versanis Bio
Based in the United States, Versanis Bio is a startup founded in 2017. Versanis Bio has been acquired. Brouky classifies it under Healthcare & Life Sciences. Brouky records 1 investor associated with the company.
Versanis Bio was a clinical-stage biopharmaceutical company developing bimagrumab, a monoclonal antibody targeting activin receptor type II to treat obesity and cardiometabolic diseases. The company was acquired by Eli Lilly in July 2023.
Explore Versanis Bio's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.